CVE:GAP - PharmaGap Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email PharmaGap Inc. (PharmaGap) is a development-stage company. The Company is principally engaged in drug development and out-licensing of drug compounds. The Company is focused on the development of novel drugs for treatment of cancer and other human disease conditions. PharmaGap's lead drug compound, GAP-107B8, is in the pre-clinical testing stage and has shown in vitro and in vivo efficacy in selected cancer types. During the year ended December 31, 2011, the Company commenced specific programs to further elucidate information regarding the pharmacokinetics and toxicity profiles of GAP-107B8. A program to develop liposomal delivery formulations of GAP-107B8 in order to optimize the delivery and safety of the drug compound was completed during 2011. The Company is developing GAP-107B8 for first clinical trials in ovarian cancer, using the intra-peritoneal route of administration. Receive GAP News and Ratings via Email Sign-up to receive the latest news and ratings for GAP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange CVE Industry N/A Sub-IndustryN/A SectorN/A Current SymbolCVE:GAP Previous Symbol CUSIPN/A CIKN/A WebN/A Phone+1-613-2873118Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable PharmaGap (CVE:GAP) Frequently Asked Questions What is PharmaGap's stock symbol? PharmaGap trades on the Canadian Venture Exchange (CVE) under the ticker symbol "GAP." Has PharmaGap been receiving favorable news coverage? News articles about GAP stock have trended somewhat positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. PharmaGap earned a daily sentiment score of 0.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an effect on the stock's share price in the near term. What other stocks do shareholders of PharmaGap own? Based on aggregate information from My MarketBeat watchlists, some companies that other PharmaGap investors own include Micron Technology (MU), Constellation Brands (STZ), Mid-America Apartment Communities (MAA), AAR (AIR), Lendlease Group (LLC), United States Brent Oil Fund (BNO), National Bank of Canada (NA), Velocity Data (VCT), Majestic Wine (WINE) and Campbell Soup (CPB). How do I buy shares of PharmaGap? Shares of GAP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. How can I contact PharmaGap? PharmaGap's mailing address is 1000 Innovation Drive, Suite 400, OTTAWA, ON K2K 2K7, Canada. The company can be reached via phone at +1-613-2873118. MarketBeat Community Rating for PharmaGap (CVE GAP)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 26 (Vote Outperform)Underperform Votes: 37 (Vote Underperform)Total Votes: 63MarketBeat's community ratings are surveys of what our community members think about PharmaGap and other stocks. Vote "Outperform" if you believe GAP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GAP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: What is a stock buyback?